Cited by 22Gastrointestinal motility and disordersGastroesophageal reflux and treatmentsNeurotransmitter Receptor Influence on Behavior

The influence of citalopram on interdigestive gastrointestinal motility in man

Open access
Janssen, P., Vos, R., Tack, J.·2010·Alimentary Pharmacology & Therapeutics

Abstract

Aliment Pharmacol Ther 2010; 32: 289–295 Summary: Background Administration of 5‐hydroxytryptamine (5HT) and selective 5HT receptor ligands modifies interdigestive motility in animals and in man. Aim To study the effect of citalopram, a selective 5‐HT reuptake inhibitor, on interdigestive motility in man. Methods In 20 healthy subjects, antroduodenojejunal motor activity was studied manometrically. Basal interdigestive motor activity was recorded until the passage of two activity fronts. Ten minutes after the second activity front, placebo or 20 mg of citalopram was administered intravenously in a double‐blind randomized fashion. Recording continued until the passage of two more activity fronts had occurred. Results Administration of citalopram induced a premature small intestinal phase 3 after 35 ± 6.4 min, compared to 120 ± 17 min after placebo P < 0.01. Citalopram shortened MMC cycle length at the expense of phase 1 and phase 2 and significantly increased the motility index during phase 2 in the antrum and the small intestine. Conclusions In the interdigestive state in man, intravenous administration of the selective 5‐HT reuptake inhibitor citalopram induces a premature intestinal phase 3 and suppresses gastric activity fronts. Phase 2 motility is stimulated both in the stomach and in the small bowel after citalopram. These data suggest that 5HT is involved in the control of interdigestive motility.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2010.04351.x

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Gershon MD, Jonakait GM. Uptake and release of 5-hydroxytryptamine by enteric 5-hydroxytryptaminergic: effects of fluoxitene (Lilley 110140) and chlori- mipramine. Br J Pharmacol 1979; 66: 7-9.
  2. Milne R, Goa KL. Citalopram. A review of its pharmacodynamic and pharmaco- kinetic properties, and therapeutic potential in depressive illness. Drugs 1991; 41: 450-77.
  3. Sarna SK, Chey WY, Condon RE, Dodds WJ, Myers T, Chang TM. Cause-and- effect relationship between motilin and migrating myoelectrical complexes. Am J Physiol 1983; 245: G277-84.

Cited by

Sorted by citations

Authors
Janssen, P., Vos, R., & Tack, J.
Affiliations
KU Leuven (BE)
Corresponding author
Tack, J.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2010-06-21
Volume
32
Issue
2
Pages
289-295
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1675789995
Cited by
22
References
40
Citations by year
2026: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 1 · 2019: 1 · 2018: 1 · 2016: 2 · 2015: 2 · 2014: 1 · 2012: 2
FWCI
0.99
Type
journal article
Language
en
Open access
Locations
  • Alimentary Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • Digital Access to Libraries (submittedVersion)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
Funders
  • Fonds Wetenschappelijk Onderzoek
  • Vlaamse regering
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
citalopram, serotonin, migrating motor complex, small intestine motility, antral motility
MeSH terms
Adult, Animals, Digestion, Double-Blind Method, Female, Gastrointestinal Motility, Humans, Jejunum, Male, Manometry, Muscle Contraction, Citalopram, Selective Serotonin Reuptake Inhibitors, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review